Sheel Biotech (NSE:SHEEL) NonCurrent Deferred Liabilities: ₹0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SHEEL Sheel Biotech Ltd NSE:SHEEL
21 GF Score
Price ₹64.00
! 2 Warning Signs
View Full Analysis

What is Sheel Biotech NonCurrent Deferred Liabilities?

Sheel Biotech NSE:SHEEL -1.69% 21 NonCurrent Deferred Liabilities is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:SHEEL with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Sheel Biotech's non-current deferred liabilities for the quarter that ended in Mar. 2026 was ₹0 Mil.

Sheel Biotech NonCurrent Deferred Liabilities Related Terms

Sheel Biotech NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Sheel Biotech's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sheel Biotech NonCurrent Deferred Liabilities Chart

Sheel Biotech Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
NonCurrent Deferred Liabilities
0.00 0.00 0.00 0.00 0.00

Sheel Biotech Semi-Annual Data
Mar22 Mar23 Mar24 Mar25 Mar26
NonCurrent Deferred Liabilities 0.00 0.00 0.00 0.00 0.00
NSE:SHEEL
21GF Score
Sheel Biotech Ltd NSE:SHEEL
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of ₹0 Mil mean?
Sheel Biotech (NSE:SHEEL) has a NonCurrent Deferred Liabilities of ₹0 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Sheel Biotech and its competitors.
Is Sheel Biotech's NonCurrent Deferred Liabilities too high?
Sheel Biotech's current NonCurrent Deferred Liabilities is ₹0 Mil. Overall, Sheel Biotech has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's NonCurrent Deferred Liabilities compare to ADM and BG?
Sheel Biotech's NonCurrent Deferred Liabilities of ₹0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Consumer Packaged Goods company?
A good NonCurrent Deferred Liabilities depends on the Consumer Packaged Goods industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Sheel Biotech and its competitors. Sheel Biotech's current NonCurrent Deferred Liabilities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current NonCurrent Deferred Liabilities of ₹0 Mil. The current NonCurrent Deferred Liabilities is ₹0 Mil. Sheel Biotech's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current NonCurrent Deferred Liabilities is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sheel Biotech Business Description

Address Guru Ravidas Marg, 8 Balaji Estates, 2nd Floor, Block-C, Kalkaji, South Delhi, New Delhi, IND, 110019
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
21GF Score

Get the complete analysis for NSE:SHEEL

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹64.00
Price